ClinicalTrials.gg
RecruitingNCT06246929HABITUpdated Jul 7, 2026

Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline

An interventional study of MBCT+w and ALED in Chronic Pain, Physical Activity and Older Adults, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Chronic Pain by Massachusetts General Hospital — 7 open to participants now, 8 under way, none of them phase 3. Chronic Pain · Massachusetts General Hospital.

Planned enrollment
Largest of 23
400 · median 60
Started
2025
with 2 others
No phase
20 of 27
5 open now
Registered
21st of 27
by date

Among the 27 studies in Chronic Pain by Massachusetts General Hospital, this one has the largest planned enrollment of the 23 interventional ones that give a count, is one of 3 that started in 2025, is one of 20 with no phase, and was the 21st registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

7 of the 27 studies in Chronic Pain by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 50 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Chronic Pain by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The investigators aim to conduct a randomized controlled trial to compare two symptom-management programs for Black older adults with early cognitive decline (self-reported confirmed by testing) and chronic pain. The programs are Mindfulness-Based Cognitive Therapy with Walking (MBCT+w) and Active Living Every Day (ALED). The investigators will assess how each program may help in improving physical, cognitive, and emotional function. The investigators will also assess whether improvements in outcomes from the two programs are maintained through a 6-month follow-up.

Read the detailed description

The investigators aim to conduct a randomized controlled trial to compare two symptom-management programs for Black older adults with early cognitive decline (self-reported or confirmed by testing) and chronic pain. The programs are Mindfulness-Based Cognitive Therapy with Walking (MBCT+w) and Active Living Every Day (ALED). The investigators will assess how each program may help in improving physical, cognitive, and emotional function outcomes. The investigators will also assess whether improvements in outcomes from the two programs are maintained through a 6-month follow-up.

The program MBCT+w is focused on learning about managing chronic pain and early cognitive decline and strategies to become more active. The ALED program focuses on learning and understanding the process of successful lifestyle change, incorporating physical activity in your day-to-day life, and strategies to manage daily activity.

The MBCT+w group meets in person for eight sessions for 90-minutes, and the ALED group meets in person for twelve sessions for 60-minutes. Each group has up to 10-12 participants. Participants receive a treatment manual. The investigators will assess how each program may help in improving physical, cognitive, and emotional function outcomes. Outcomes will be assessed at 3 points: baseline, post program, and 6-month follow-up. Assessments involve self-report questionnaires, a walk test, and a neuropsychological exam. The investigators will assess whether improvements in outcomes from the two programs are maintained through a 6-month follow-up.

03

Conditions studied

  • Chronic Pain
  • Physical Activity
  • Older Adults
  • Mild Cognitive Impairment

Keywords

  • Black Older Adults
  • African Americans
  • Subjective Cognitive Decline
  • Memory Related Problems
  • Pain
  • Cognition Disorders
04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Black adults, male and females, age 50 or older
  • Have nonmalignant musculoskeletal chronic pain for more than three months
  • Reports early cognitive decline (subjective and objective)
  • Telephone Interview for Cognitive Status-41 score greater than or equal to 31
  • Functional Activities Questionnaire score less than 9
  • English fluency/literacy
  • Free of concurrent psychotropic or pain medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic or pain medication for a minimum of 6 weeks and willing to maintain stable dose
  • Cleared by medical doctor for study participation and no self-reported concerns about physical functioning on the revised Physical Activity Readiness Questionnaire (PAR-Q; score 0)

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with dementia or neurodegenerative disease
  • Regular use of nonpharmacological pain management
  • Diagnosed with serious mental illness or substance abuse
  • Current suicidal ideation on self-report
  • Engagement of regular exercise for more than 30 minutes daily
  • Unable to walk
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Mindfulness-Based Cognitive Therapy With Walking (MBCT+w)

    MBCT+w uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions and weekly practice assignments (homework). The MBCT+w sessions teach skills and strategies to manage early cognitive concerns and chronic pain. The format is an 8-week program with 90-minute weekly meetings that will focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. MBCT+w uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

    Behavioral: MBCT+w

  • Active comparator
    Active Living Every Day (ALED)

    ALED is a behavior change program. ALED offers different options to traditional exercise program to help participants overcome barriers to physical activity and increase their physical activity. The format is a 12-week program with 60-minute sessions that include a short lecture and group discussions to help participants set goals, decrease barriers to exercise, and find an activity they enjoy. The ALED program is conducted in the same format as MBCT+w, but participants are not taught the mind-body, walking or cognitive-behavioral skills. ALED will also use a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

    Behavioral: ALED

Interventions

  • BehavioralMBCT+w

    MBCT+w uses a multimodal approach to introduce and reinforce new skills, including didactics, in-session activities, discussions and weekly practice assignments (homework). The MBCT+w sessions teach skills and strategies to manage early cognitive concerns and chronic pain. The format is an 8-week program with 90-minute weekly meetings that will focus on relaxation response strategies, cognitive behavioral training, positive psychology and mind-body interactions. MBCT+w uses a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

  • BehavioralALED

    ALED is a behavior change program. ALED offers different options to traditional exercise program to help participants overcome barriers to physical activity and increase their physical activity. The format is a 12-week program with 60-minute sessions that include a short lecture and group discussions to help participants set goals, decrease barriers to exercise, and find an activity they enjoy. The ALED program is conducted in the same format as MBCT+w, but participants are not taught the mind-body, walking or cognitive-behavioral skills. ALED will also use a wrist-worn digital monitoring device (ActiGraph) for recording of physical activity.

06

What researchers measure

Primary outcomes

  1. Patient Reported Outcomes Measurement Information System (PROMIS) Physical Function

    Change in participant's self-reported performance of everyday physical activities, with items ranging from 1-4. Higher T scores indicate greater physical function.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

Secondary outcomes

  1. ActiGraph GT9X Link Accelerometer

    Measure the change in steps during the 7 days preceding baseline assessment, throughout intervention period, and 7 days preceding 6-month follow-up.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  2. Six-minute walk test (6MWT)

    Assesses distance walked in 6 minutes.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  3. Montreal Cognitive Assessment (MoCA)

    A comprehensive test that assesses eight cognitive abilities (orientation, short-term memory, executive function, clock drawing, animal naming, language abilities, abstraction, and attention). Higher total scores (0-30) indicate greater cognitive functioning.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  4. Everyday Cognitive Scale (eCog-12)

    Rating of participant's self-reported cognitively mediated functional abilities, with items ranging 1-5. Scores are calculated by averaging the 12 items, and range 1-5, with higher scores indicating greater cognitive decline.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  5. PROMIS Depression

    Rating of participant's self-reported negative mood, social cognition and views of self, with items ranging from 1-5. Higher T scores indicate high levels of depression.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  6. PROMIS Anxiety

    Rating of participant's self-reported fear, anxious, hyperarousal and somatic symptoms pertaining to arousal, with items ranging from 1-5. Higher T scores indicate higher levels of anxiety.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

Other outcomes

  1. Numerical Rating Scale (NRS)

    Rating of participant's self-reported pain at rest and with activity using a Likert Scale with 0 being no pain and 10 being worst possible pain.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  2. UCLA loneliness scale 8-item (UCLA-8)

    Rating of participant's self-reported subjective feelings of loneliness and social isolation, with items ranging 0-3. Higher scores indicate higher feelings of loneliness.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  3. PROMIS Emotional Support v4a

    Rating of participant's self-reported subjective feelings of emotional support from others, with items ranging 1-5. Higher T scores indicate higher emotional support.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  4. Zarit Burden Interview (12-item)

    Rating of caregiver's self-reported subjective feelings of his or her levels of burden for caring for a person with a particular diagnosis, with items ranging 0-4. Higher scores indicate greater feelings of burden.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

  5. Caregiver Strain Questionnaire Short Form

    Rating of caregiver's self-reported subjective feelings of strain experienced with sleep, finances, physical movements, and emotional adjustments, with items ranging 0-1. Higher scores indicate greater feelings of strain.

    Time frame: 0 Weeks, 12 Weeks, 6 Months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Klein KG, Seward M, Harley D, Mace R, Morehead M, Parker RA, Sylvia LG, Bartels SJ, Obler D, Callahan J, Craddock K, Reed R, Atkinson F, Joo JH, Macklin E, Okereke OI, Vranceanu AM. Healthy aging as Black adults, in it together (HABIT): Protocol for a comparative effectiveness trial to address comorbid chronic pain and early cognitive decline among older, community-based Black adults. Contemp Clin Trials. 2026 Jun;165:108292. doi: 10.1016/j.cct.2026.108292. Epub 2026 Mar 26. PubMed 41903741 ↗
  • Mace RA, Gates MV, Popok PJ, Kulich R, Quiroz YT, Vranceanu AM. Feasibility Trial of a Mind-Body Activity Pain Management Program for Older Adults With Cognitive Decline. Gerontologist. 2021 Nov 15;61(8):1326-1337. doi: 10.1093/geront/gnaa179. PubMed 33159516 ↗
  • Mace RA, Gates MV, Bullard B, Lester EG, Silverman IH, Quiroz YT, Vranceanu AM. Development of a Novel Mind-Body Activity and Pain Management Program for Older Adults With Cognitive Decline. Gerontologist. 2021 Apr 3;61(3):449-459. doi: 10.1093/geront/gnaa084. PubMed 32601670 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2028, 47 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 47 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2024
First posted
Feb 7, 2024
StartActual
Jan 10, 2025
Primary completionEst.
Dec 15, 2028
CompletionEst.
Dec 15, 2028
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06246929
Responsible party
Olivia I.Okereke, MD (Director of Geriatric Psychiatry, Massachusetts General Hospital) — Principal investigator
First posted
Feb 7, 2024
Start date
Jan 10, 2025
Primary completion
Dec 15, 2028 (estimated)
Completion
Dec 15, 2028 (estimated)
Last update
Jul 7, 2026

Study contacts

Mallory Morehead, MPH
Contact
mmorehead@mgb.org
(978) 580-3153
Adjoa Acquaah, BA
Contact
aacquaah@mgh.hardvard.edu
(617) 726-8103
Olivia Okereke, MD, MS
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion